Earth Science Tech, Inc (ETST) Fair Value & Analysis
Healthcare · US · Market cap $51.3M
Earth Science Tech, Inc
ETST · US
Fair value as of: Jul 29, 2026
From 24 valuation models · updated 12 days ago
Share price −32.5% over the past month.
A solid business, screening 94% undervalued on our models.
What matters now
- The rarer combination: high quality (74/100) AND below fair value. That earns a closer look rather than a quick verdict.
- The price is below even our cautious bear case ($0.1300). The market is more pessimistic than our downside scenario.
- The model range is unusually wide ($0.1300 to $0.3800). The outcome hinges heavily on assumptions, so read the point estimate with caution.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 29, 2026.
How to read this chart
60‑month range $0.0103 – $0.3199 · fair‑value band $0.1300 – $0.3800 · the $0.0979 price screens below the $0.1900 fair value. Dashed = 300-day average. As of Jul 29, 2026.
Analysis
Earth Science Tech, Inc (ETST) currently trades at $0.0979, while our model-based Fair Value estimate is $0.1900, implying the stock looks roughly 94.1% undervalued today. The Quality Score stands at 74/100 (solid quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.
Over the trailing twelve months, Earth Science Tech, Inc generated revenue of $34.9M at a net margin of 10.1%. Revenue grew 14.1% year over year. It earns a return on equity of 76.8%. The balance sheet holds a net cash position of $1.1M. Fundamentals as of Jul 29, 2026
Our scenario range runs from $0.1300 (bear case) to $0.3800 (bull case); at $0.0979, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 59% below its 52-week high, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -49% fair-value upside, at 94%, ETST screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 24 models by family
Widest divergence: Growth Earnings ($0.5200) versus Asset-Based ($0.0100). Highest evidence: Growth DCF (80).
Notify me when ETST reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 29, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 74 · Market factors (momentum, volatility) 9
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Earth Science Tech, Inc., together with its subsidies, focuses on health and wellness industry. It engages in compounding pharmaceuticals, telemedicine, and real estate development activities.
Full company description
Earth Science Tech, Inc., together with its subsidies, focuses on health and wellness industry. It engages in compounding pharmaceuticals, telemedicine, and real estate development activities. The company also operates Peaks, a telemedicine referral platform focused on health and wellness for men and women; and pharmacies under the RxCompound and Mister Meds name. In addition, it is involved in the development and management of real estate assets. The company was formerly known as Ultimate Novelty Sports, Inc. and changed its name to Earth Science Tech, Inc. in March 2014. Earth Science Tech, Inc. was incorporated in 2010 and is headquartered in Miami, Florida.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Earth Science Tech, Inc reported revenue of $33.1M in FY2025 versus $141K in FY2021, a compound +291.5%/yr. Reported net income was $3.3M in FY2025.
Watch ETST: get an alert when its fair value changes →
Peer Group
Drug Manufacturers - Specialty & Generic · 623 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Drug Manufacturers - Specialty & Generic median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate (as of Jul 29, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Jiangsu Hengrui Pharmaceuticals Co 600276 | ¥53.19 | ¥25.94 | -51% |
| Sun Pharmaceutical Industries Limited SUNPHARMA | ₹1,933 | ₹989.50 | -49% |
| Divi's Laboratories Limited DIVISLAB | ₹7,316 | ₹1,943 | -73% |
| Torrent Pharmaceuticals Limited TORNTPHARM | ₹4,763 | ₹1,329 | -72% |
| PharmaEssentia Corporation 6446 | 1,285 TWD | 221.01 TWD | -83% |
| Cipla Limited CIPLA | ₹1,439 | ₹1,001 | -30% |
| Zydus Lifesciences Limited ZYDUSLIFE | ₹1,151 | ₹703.32 | -39% |
| Lupin Limited LUPIN | ₹2,443 | ₹2,477 | +1% |
| Mankind Pharma Limited MANKIND | ₹2,484 | ₹983.11 | -60% |
| Dr. Reddy's Laboratories Limited DRREDDY | ₹1,211 | ₹874.79 | -28% |
Compare Earth Science Tech, Inc with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Earth Science Tech, Inc (ETST) overvalued or undervalued?
What is the fair value of ETST?
What is the quality score of ETST?
What is the revenue of Earth Science Tech, Inc (ETST)?
What is the net profit margin of ETST?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Earth Science Tech, Inc and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.